JoVE Logo

Iniciar sesión

Chapter 11

Cardiovascular Drugs: Anticoagulants and Antianginal Agents

Fármacos anticoagulantes: heparinas de bajo peso molecular
Fármacos anticoagulantes: heparinas de bajo peso molecular
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, ...
Medicamentos anticoagulantes: antagonistas de la vitamina K y anticoagulantes orales directos
Medicamentos anticoagulantes: antagonistas de la vitamina K y anticoagulantes orales directos
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K ...
Fármacos antiplaquetarios: síntesis de prostaglandinas, P2Y12 e inhibidores de la glicoproteína IIb/IIIa
Fármacos antiplaquetarios: síntesis de prostaglandinas, P2Y12 e inhibidores de la glicoproteína IIb/IIIa
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood ...
Medicamentos hipolipemiantes: estatinas y agentes diversos
Medicamentos hipolipemiantes: estatinas y agentes diversos
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. ...
Cardiopatía isquémica: descripción general
Cardiopatía isquémica: descripción general
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from ...
Fármacos antianginosos: nitratos y betabloqueantes
Fármacos antianginosos: nitratos y betabloqueantes
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart. ...
Fármacos antianginosos: bloqueadores de los canales de calcio y ranolazina
Fármacos antianginosos: bloqueadores de los canales de calcio y ranolazina
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers ...
JoVE Logo

Privacidad

Condiciones de uso

Políticas

Investigación

Educación

ACERCA DE JoVE

Copyright © 2025 MyJoVE Corporation. Todos los derechos reservados